STATE STREET CORP - NEOLEUKIN THERAPEUTICS INC ownership

NEOLEUKIN THERAPEUTICS INC's ticker is NLTX and the CUSIP is 64049K104. A total of 39 filers reported holding NEOLEUKIN THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
STATE STREET CORP ownership history of NEOLEUKIN THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$101,721
+18.6%
122,5560.0%0.00%
Q1 2023$85,789
-31.2%
122,556
-50.0%
0.00%
Q4 2022$124,762
+60.0%
245,112
+100.0%
0.00%
Q3 2022$78,000
-38.1%
122,5560.0%0.00%
Q2 2022$126,000
-88.6%
122,556
-79.1%
0.00%
Q1 2022$1,101,000
-60.6%
585,627
+1.0%
0.00%
Q4 2021$2,795,000
-36.7%
579,976
-5.0%
0.00%
Q3 2021$4,413,000
-61.3%
610,424
-50.6%
0.00%
-100.0%
Q2 2021$11,400,000
-41.4%
1,235,098
-21.8%
0.00%0.0%
Q1 2021$19,438,000
+17.1%
1,579,068
+34.1%
0.00%0.0%
Q4 2020$16,601,000
+148.6%
1,177,350
+111.5%
0.00%
Q3 2020$6,679,000
-20.7%
556,577
+9.7%
0.00%
-100.0%
Q2 2020$8,419,000
+5262.4%
507,140
+3587.5%
0.00%
Q1 2020$157,000
+4.7%
13,753
+13.2%
0.00%
Q4 2019$150,000
+328.6%
12,1530.0%0.00%
Q3 2019$35,00012,1530.00%
Other shareholders
NEOLEUKIN THERAPEUTICS INC shareholders Q2 2023
NameSharesValueWeighting ↓
Opaleye Management Inc. 1,225,000$15,080,0002.22%
EcoR1 Capital, LLC 3,122,704$38,440,0001.70%
Redmile Group, LLC 4,117,569$50,687,0000.71%
HighVista Strategies LLC 71,235$877,0000.65%
Boxer Capital, LLC 1,501,058$18,478,0000.63%
Baker Brothers Advisors 3,821,740$47,046,0000.20%
Sio Capital Management, LLC 38,312$472,0000.10%
Highland Private Wealth Management 46,999$579,0000.10%
Point72 Asset Management, L.P. 1,308,600$16,109,0000.08%
Granahan Investment Management 200,518$2,468,0000.05%
View complete list of NEOLEUKIN THERAPEUTICS INC shareholders